BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 15, 2025
See today's BioWorld Science
Home
» Promising anti-IGF-1R antibody for thyroid eye disease has extended half-life and can be self-administered
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Ocular
Promising anti-IGF-1R antibody for thyroid eye disease has extended half-life and can be self-administered
May 4, 2023
No Comments
Thyroid eye disease (TED; also known as Graves' ophthalmopathy or thyroid-associated...
BioWorld Science
Conferences
Ocular
